English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Mar 17, 2026
Researchers link Roseburia gut bacteria to muscle strength and physical fitness
Patient Daily
| Mar 17, 2026
UBC Okanagan study finds falls prevention clinic yields strong health and economic returns
Patient Daily
| Mar 17, 2026
Study finds exercise reduces cognitive decline during chemotherapy for cancer patients
Patient Daily
| Mar 17, 2026
New imaging method maps gene activity across entire zebrafish embryo
Patient Daily
| Mar 17, 2026
Experimental therapy eliminates pancreatic precancerous cells in mice study
Patient Daily
| Mar 17, 2026
Study identifies seven distinct types of hyperarousal across mental disorders
Patient Daily
| Mar 17, 2026
Study identifies immune cells and RANK protein as fertility regulators
Patient Daily
| Mar 17, 2026
PSMA PET/CT scan may halve unnecessary prostate biopsies
Trending
+
Regulatory
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
+
Regulatory
Patient Daily
| Apr 29, 2026
USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
+
Regulatory
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
« First
«
…
42
43
44
45
46
47
48
…
»
Last »